Literature DB >> 16110849

Dramatic response to granulocytapheresis in a Crohn's disease case complicated by hepatitis C virus.

Koji Sawada1, Kunio Ohnishi, Takeshi Kusaka, Yoshika Matoba, Ken Fukunaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16110849     DOI： 10.1007/s10620-005-2875-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

Review 1.  IFN-alpha and IFN-beta: a link between immune memory and chronic inflammation.

Authors:  A N Akbar; J M Lord; M Salmon
Journal:  Immunol Today       Date:  2000-07

2.  A new treatment for HCV-ulcerative colitis comorbidity intolerant to INF-alpha.

Authors:  Koji Sawada; Kunio Ohnishi; Ken Fukunaga; Takashi Shimoyama
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

Review 3.  Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes.

Authors:  Abby R Saniabadi; Hiroyuki Hanai; Ken Takeuchi; Kazuo Umemura; Mitsuyoshi Nakashima; Taro Adachi; Chikako Shima; Ingvar Bjarnason; Robert Lofberg
Journal:  Ther Apher Dial       Date:  2003-02       Impact factor: 1.762

4.  Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.

Authors:  T Shimoyama; K Sawada; N Hiwatashi; T Sawada; K Matsueda; A Munakata; H Asakura; T Tanaka; R Kasukawa; K Kimura; Y Suzuki; Y Nagamachi; T Muto; H Nagawa; B Iizuka ; S Baba; M Nasu; T Kataoka; N Kashiwagi; A R Saniabadi
Journal:  J Clin Apher       Date:  2001       Impact factor: 2.821

Review 5.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

6.  Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-alpha2b plus ribavirin combination therapy: a prospective study in patients with high plasma HCV viraemia.

Authors:  K Sawada; N Masaki; S Hayashi; M Zeniya; T Ishikawa; H Takahashi; K Ohnishi; K Fukunaga; N Hara; T Yamamoto; T Hada; G Toda
Journal:  J Viral Hepat       Date:  2005-05       Impact factor: 3.728

7.  Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus.

Authors:  M Crovatto; G Pozzato; F Zorat; E Pussini; F Nascimben; S Baracetti; M G Grando; C Mazzaro; M Reitano; M L Modolo; P Martelli; A Spada; G Santini
Journal:  Haematologica       Date:  2000-04       Impact factor: 9.941

8.  Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis.

Authors:  Katsuya Hiraishi; Yuji Takeda; Noriyuki Shiobara; Hiromu Shibusawa; Fumie Jimma; Nobuhito Kashiwagi; Abby R Saniabadi; Masakazu Adachi
Journal:  Ther Apher Dial       Date:  2003-06       Impact factor: 1.762

9.  Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy.

Authors:  P Halfon; G Halimi; M Bourlière; D Ouzan; J Durant; H Khiri; L Mercier; V Gerolami; G Cartouzou
Journal:  Liver       Date:  2000-10
  9 in total
  2 in total

1.  Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease.

Authors:  Alina M Allen; W Ray Kim; Joseph Larson; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

Review 2.  Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease.

Authors:  Farah Yasmin; Hala Najeeb; Unaiza Naeem; Abdul Moeed; Thoyaja Koritala; Salim Surani
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.